Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Terminated
Trial end date:
2016-08-31
Target enrollment:
Participant gender:
Summary
This phase 2 study evaluates the sequential combination of decitabine then midostaurin for
the treatment of newly-diagnosed acute myeloid leukemia (AML) in older patients.